Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Impact of semaglutide 2.4 mg and oral semaglutide 25 mg on QoL in women with obesity: A post hoc analysis of the STEP and OASIS programs by menopausal status
Maria Daniela Hurtado Andrade1,2; Rebecca Dunsmoor-Su3,4; Emilia Huvinen5; Naveen Rathor6; Nanette Santoro7; Lauren Wilson8; Sushmita Yaganti8; Santiago Palacios9